| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 269.847 | 926.463 | 809.183 | 676.538 | 794.911 | 796.338 | 952.153 | 798.477 |
| Total Income - EUR | - | 741 | 274.087 | 928.657 | 820.745 | 678.831 | 795.001 | 796.444 | 957.164 | 823.299 |
| Total Expenses - EUR | - | 5.086 | 205.439 | 489.741 | 429.233 | 361.068 | 438.959 | 486.412 | 565.198 | 590.253 |
| Gross Profit/Loss - EUR | - | -4.345 | 68.648 | 438.917 | 391.513 | 317.764 | 356.042 | 310.032 | 391.966 | 233.047 |
| Net Profit/Loss - EUR | - | -4.345 | 65.939 | 429.655 | 384.487 | 312.964 | 349.790 | 302.913 | 343.688 | 200.970 |
| Employees | - | 0 | 3 | 4 | 4 | 2 | 2 | 2 | 2 | 4 |
Check the financial reports for the company - I-Med Optogyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 221.054 | 270.194 | 231.889 | 183.999 | 410.873 | 374.423 | 340.833 | 507.265 | 450.666 |
| Current Assets | - | 100.020 | 111.667 | 217.907 | 214.184 | 45.572 | 40.441 | 257.345 | 271.938 | 253.716 |
| Inventories | - | 13.161 | 22.276 | 31.300 | 26.658 | 26.206 | 27.629 | 32.068 | 31.201 | 26.620 |
| Receivables | - | 0 | 55 | 118.756 | 135.411 | 1.656 | 7 | 203.581 | 1.618 | 132.361 |
| Cash | - | 86.859 | 89.337 | 67.850 | 52.116 | 17.710 | 12.805 | 21.696 | 239.118 | 94.735 |
| Shareholders Funds | - | -4.278 | 62.836 | 429.732 | 384.563 | 313.038 | 349.863 | 302.986 | 343.761 | 201.042 |
| Social Capital | - | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | 325.352 | 325.413 | 20.063 | 16.113 | 143.407 | 65.001 | 297.914 | 240.698 | 334.428 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 2.266 | 194.743 | 168.933 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - I-Med Optogyn Srl